Filtered By:
Procedure: Liver Transplant

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 13373 results found since Jan 2013.

Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
The objective of this analysis is to determine the effectiveness of solid organ transplantation in persons with end stage organ failure (ESOF) and human immunodeficiency virus (HIV+) CLINICAL NEED: CONDITION AND TARGET POPULATION Patients with end stage organ failure who have been unresponsive to other forms of treatment eventually require solid organ transplantation. Similar to persons who are HIV negative (HIV-), persons living with HIV infection (HIV+) are at risk for ESOF from viral (e.g. hepatitis B and C) and non-viral aetiologies (e.g. coronary artery disease, diabetes, hepatocellular carcinoma). Additionally, H...
Source: Ontario Health Technology Assessment Series - December 20, 2015 Category: Journals (General) Tags: Ont Health Technol Assess Ser Source Type: research

Review article: sarcopenia in cirrhosis – aetiology, implications and potential therapeutic interventions
ConclusionSarcopenia in cirrhosis has a complex pathogenesis and simple dietary interventions are insufficient. Improved understanding of the multiple mechanisms involved should allow the development of more effective therapies, which target the specific underlying metabolic derangements.
Source: Alimentary Pharmacology and Therapeutics - February 5, 2016 Category: Drugs & Pharmacology Authors: M. Sinclair, P. J. Gow, M. Grossmann, P. W. Angus Tags: Review Article Source Type: research

Search for Genetic Modifiers of PSC: Time to Increase the Number of Needles in the Haystack.
Authors: Krawczyk M, Lammert F Abstract Primary sclerosing cholangitis (PSC) belongs to the most obscure liver diseases. Patients with progressive PSC require liver transplantation as only therapeutic option. Previously several HLA- and non-HLA-associated PSC risk variants have been discovered, however their involvement in the development of PSC seems to be minor in comparison to environmental determinants. Lately, variant rs853974 at the RSPO3 gene locus has been shown to modulate the course of PSC. Here we briefly discuss the phenotypes related to this polymorphism and propose alternative directions of research t...
Source: Annals of Hepatology - October 24, 2017 Category: Gastroenterology Tags: Ann Hepatol Source Type: research

The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease.
Authors: Mandelia C, Kabbany MN, Conjeevaram Selvakumar PK, Alkhouri N Abstract Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the obesity epidemic. Recent studies have clearly shown that the stage of fibrosis in adults with NAFLD is the most important histological feature in long-term outcomes and the development of liver-related complications. Despite the paucity of data regarding the natural history of pediatric NAFLD, its progression to cirrhosis and end-stage liver disease requiring liver transplantation is well documented. Given the high prevalence of NAFLD in children and adults, th...
Source: Future Medicine: Biomarkers in Medicine - March 10, 2018 Category: Internal Medicine Tags: Biomark Med Source Type: research

Search for Genetic Modifiers of PSC: Time to Increase the Number of Needles in the Haystack.
Authors: Krawczyk M, Lammert F Abstract Primary sclerosing cholangitis (PSC) belongs to the most obscure liver diseases. Patients with progressive PSC require liver transplantation as only therapeutic option. Previously several HLA- and non-HLA-associated PSC risk variants have been discovered, however their involvement in the development of PSC seems to be minor in comparison to environmental determinants. Lately, variant rs853974 at the RSPO3 gene locus has been shown to modulate the course of PSC. Here we briefly discuss the phenotypes related to this polymorphism and propose alternative directions of research t...
Source: Annals of Hepatology - June 9, 2019 Category: Gastroenterology Tags: Ann Hepatol Source Type: research

Contribution of Turkey in Liver Transplant Research: A Scopus Database Search
CONCLUSIONS: Among countries, Turkey had the most living donor liver transplants in 2019 and could serve as a model to European countries for donor shortages. Although the United States performs 5 times more liver transplants than Turkey, their publications rate was almost 22 times more. Combining a workload of performing research and publishing along with transplant surgery is together hard to master. Although Turkey has valuable experiences and has opened frontiers in transplantation, publications need to keep up with their hard work and innovations.PMID:35607793 | DOI:10.6002/ect.2021.0491
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - May 24, 2022 Category: Transplant Surgery Authors: Oru ç Numan Gökçe Sevil Alkan Source Type: research

Interventions for preventing thrombosis in solid organ transplant recipients
CONCLUSIONS: Overall, there is a paucity of research in the field of graft thrombosis prevention. Due to a lack of high quality evidence, it remains unclear whether any therapy is able to reduce the rate of early graft thrombosis in any type of solid organ transplant. UFH may increase the risk of major bleeding in kidney transplant recipients, however this is based on low certainty evidence. There is no evidence from RCTs to guide anti-thrombotic strategies in liver, heart, lung, or other solid organ transplants. Further studies are required in comparing anticoagulants, antiplatelets to placebo in solid organ transplantati...
Source: Cochrane Database of Systematic Reviews - March 15, 2021 Category: General Medicine Authors: Vignesh Surianarayanan Thomas J Hoather Samuel J Tingle Emily R Thompson John Hanley Colin H Wilson Source Type: research

Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients
CONCLUSIONS: Interventions to increase taking and dosing adherence to immunosuppressant therapy may be effective; however, our findings suggest that current evidence in support of interventions to increase adherence to immunosuppressant therapy is overall of low methodological quality, attributable to small sample sizes, and heterogeneity identified for the types of interventions. Twenty-four studies are currently ongoing or awaiting assessment (3248 proposed participants); therefore, it is possible that findings may change with the inclusion of these large ongoing studies in future updates.PMID:36094829 | PMC:PMC9466987 |...
Source: Cochrane Database of Systematic Reviews - September 12, 2022 Category: General Medicine Authors: Lisa Mellon Frank Doyle Anne Hickey Kenneth D Ward Declan G de Freitas P Aiden McCormick Oisin O'Connell Peter Conlon Source Type: research

Synbiotics, prebiotics and probiotics for solid organ transplant recipients
CONCLUSIONS: This review highlights the severe lack of high-quality RCTs testing the efficacy of synbiotics, prebiotics or probiotics in solid organ transplant recipients. We have identified significant gaps in the evidence. Despite GI symptoms and postoperative infection being the most common reasons for high antibiotic use in this patient population, along with increased morbidity and the growing antimicrobial resistance, we found very few studies that adequately tested these as alternative treatments. There is currently no evidence to support or refute the use of synbiotics, prebiotics, or probiotics in solid organ tran...
Source: Cochrane Database of Systematic Reviews - September 20, 2022 Category: General Medicine Authors: Tess E Cooper Nicole Scholes-Robertson Jonathan C Craig Carmel M Hawley Martin Howell David W Johnson Armando Teixeira-Pinto Allison Jaure Germaine Wong Source Type: research